The Mark Foundation Funds Eight Projects at the Intersection of Artificial Intelligence and Cancer Research BioSpace

NEW YORK – Can 3D renderings of pancreatic cancer tumors provide insights that improve the prognosis for one of the deadliest cancer types? Can machine learning help us better predict which patients will benefit from immunotherapies, which currently have a 30-50 percent success rate? And can a smartphone app be a tool in early cancer detection? These are just some of the questions researchers are looking to answer with funding provided by The Mark Foundation for Cancer Research (MFCR). Details about each project funded in today's announcement are below.